 | Efficiently rules out risk of imminent delivery
It has previously been shown that 94% of women with a cervical phIGFBP-1 concentration less than 10 ėg/l did not deliver preterm or within two weeks of the sampling. None of these women delivered before week 35. Among the women admitted to the hospital with preterm contractions and who delivered preterm, 88% had phIGFBP-1 higher than 10 ėg/l. Recent studies have confirmed these findings. Actim Partus helps you identify the patients with an elevated risk of delivering preterm. And more specifically, a negative test result is a safe indication that imminent delivery or delivery within two weeks is highly unlikely.  |
| Semen and urine have no effect on test results
Most bodily fluids potentially contaminating a cervical sample, such as semen and urine, contain only trace quantities of phosphorylated IGFBP-1. Therefore a recent intercourse has no effect on the results of the Actim Partus test. Since preterm contractions may be induced by the prostaglandins in seminal fluid, several symptomatic women may recently have had intercourse. These patients do not need to be excluded when using the Actim Partus test.  |
|
